| 8645583 |
1996 |
TP53 mutation |
USA |
TP53 |
Details |
| 10030668 |
1998 |
p16INK4A methylation |
USA |
CDKN2A |
Details |
| 11313998 |
2001 |
p14ARF mutation |
Canada |
CDKN2A |
Details |
| 11313998 |
2001 |
TP53 mutation |
Canada |
TP53 |
Details |
| 11393537 |
2001 |
3p25-p26 loss of heterozygosity (LOH) |
Canada |
NA |
Details |
| 11854066 |
2002 |
MTS1 mutation |
USA |
S100A4 |
Details |
| 12543777 |
2003 |
IGF2R polymorphisms |
USA |
IGF2R |
Details |
| 15217930 |
2004 |
p27 mutation |
USA |
PSMD9 |
Details |
| 18497987 |
2008 |
SFRP1 methylation |
USA |
SFRP1 |
Details |
| 18497987 |
2008 |
SFRP2 methylation |
USA |
SFRP1 |
Details |
| 18497987 |
2008 |
SFRP5 methylation |
USA |
SFRP1 |
Details |
| 18538015 |
2008 |
TSC promoter methylation |
USA |
TSC1 |
Details |
| 19702947 |
2009 |
HBD-1 mutation |
USA |
DEFB1 |
Details |
| 20435510 |
2010 |
rs10183087 |
USA |
ICOS |
Details |
| 20435510 |
2010 |
rs231775 |
USA |
CTLA4 |
Details |
| 20435510 |
2010 |
rs3181100 |
USA |
CD28 |
Details |
| 20435510 |
2010 |
rs3181113 |
USA |
CD28 |
Details |
| 20435510 |
2010 |
rs4404254 |
USA |
ICOS |
Details |
| 20435510 |
2010 |
rs4553808 |
USA |
CTLA4 |
Details |
| 20537188 |
2010 |
10p12 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
11q13 amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
11q23-25 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
12q22 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
12q24 amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
14q23-32 amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
16q22 amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
18q11.2 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
1p21 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
20q amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
21q deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
22q deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
3q21-29 amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
5p15 amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
5q11-12 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
5q14-15 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
5q31 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
7p12 amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
8p21-22 deletion |
USA |
NA |
Details |
| 20537188 |
2010 |
8q21-24 amplification |
USA |
NA |
Details |
| 20537188 |
2010 |
9p21 deletion |
USA |
NA |
Details |
| 20736372 |
2010 |
rs2279744 |
USA |
MDM2 |
Details |
| 20736372 |
2010 |
rs937283 |
USA |
MDM2 |
Details |
| 20813562 |
2010 |
BRAF mutation |
USA |
BRAF |
Details |
| 20813562 |
2010 |
KRAS mutation |
USA |
KRAS |
Details |
| 20813562 |
2010 |
PIK3CA mutation |
USA |
PIK3CA |
Details |
| 21782343 |
2011 |
EDNRB methylation |
USA |
EDNRB |
Details |
| 22359620 |
2012 |
EGFRvIII mutation |
Canada |
EGFR |
Details |
| 22470160 |
2012 |
miR-10a CNV |
USA |
MIR10A |
Details |
| 22470160 |
2012 |
miR-140-3p CNV |
USA |
MIR140 |
Details |
| 22470160 |
2012 |
miR-149 CNV |
USA |
MIR149 |
Details |
| 22470160 |
2012 |
miR-192 CNV |
USA |
MIR192 |
Details |
| 22470160 |
2012 |
miR-29a CNV |
USA |
MIR29A |
Details |
| 22470160 |
2012 |
miR-29c CNV |
USA |
MIR29C |
Details |
| 22470160 |
2012 |
miR-34c-5p CNV |
USA |
MIR34C |
Details |
| 23227881 |
2013 |
VEGF+405 G/C |
USA |
VEGFA |
Details |
| 23227881 |
2013 |
VEGF+936 C/T |
USA |
VEGFA |
Details |
| 23227881 |
2013 |
VEGF-1154 G/A |
USA |
VEGFA |
Details |
| 23227881 |
2013 |
VEGF-2578 C/A |
USA |
VEGFA |
Details |
| 23227881 |
2013 |
VEGF-460 C/T |
USA |
VEGFA |
Details |
| 23619168 |
2013 |
Gain of 3q |
USA |
NA |
Details |
| 23619168 |
2013 |
Gain of 8q |
USA |
MYC |
Details |
| 23619168 |
2013 |
Gain of 9q |
USA |
NFIB |
Details |
| 23619168 |
2013 |
Loss of 18p |
USA |
NA |
Details |
| 23619168 |
2013 |
Loss of 3p |
USA |
FHIT |
Details |
| 23619168 |
2013 |
Loss of 8p |
USA |
CSMD1 |
Details |
| 23619168 |
2013 |
Loss of 9p |
USA |
NFIB |
Details |
| 23870134 |
2013 |
rs1799724 |
USA |
TNF |
Details |
| 23870134 |
2013 |
rs1799964 |
USA |
TNF |
Details |
| 23870134 |
2013 |
rs1800629 |
USA |
TNF |
Details |
| 23870134 |
2013 |
rs1800630 |
USA |
TNF |
Details |
| 24277457 |
2014 |
NOTCH1 mutation |
USA |
NOTCH1 |
Details |
| 24277457 |
2014 |
TP53 mutation |
USA |
TP53 |
Details |
| 25197641 |
2014 |
BRCA2 methylation |
USA |
BRCA1 |
Details |
| 25197641 |
2014 |
ELYS methylation |
USA |
AHCTF1 |
Details |
| 25197641 |
2014 |
HOXD4 methylation |
USA |
HOXD4 |
Details |
| 25197641 |
2014 |
MDR1 methylation |
USA |
ABCB1 |
Details |
| 25197641 |
2014 |
NIT1 methylation |
USA |
NIT1 |
Details |
| 25197641 |
2014 |
p21 methylation |
USA |
KRAS |
Details |
| 25197641 |
2014 |
RARB methylation |
USA |
RARB |
Details |
| 25527207 |
2014 |
KRT13 promoter hypermethylation |
USA |
KRT13 |
Details |
| 26247464 |
2015 |
CDKN2A amplification |
USA |
CDKN2A |
Details |
| 26247464 |
2015 |
CDKN2A deletion |
USA |
CDKN2A |
Details |
| 26247464 |
2015 |
EGFR amplification |
USA |
EGFR |
Details |
| 26247464 |
2015 |
EGFR deletion |
USA |
EGFR |
Details |
| 26247464 |
2015 |
ERBB2 amplification |
USA |
ERBB2 |
Details |
| 26247464 |
2015 |
ERBB2 deletion |
USA |
ERBB2 |
Details |
| 26247464 |
2015 |
FAT1 amplification |
USA |
FAT1 |
Details |
| 26247464 |
2015 |
FAT1 deletion |
USA |
FAT1 |
Details |
| 26247464 |
2015 |
Frequent large-region-gain of 3q |
USA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-gain of 5p |
USA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-gain of 8q |
USA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-loss of 3p |
USA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-loss of 8p |
USA |
NA |
Details |
| 26247464 |
2015 |
Frequent large-region-loss of 9p |
USA |
NA |
Details |
| 26247464 |
2015 |
rs16904097 |
USA |
CCDC26 |
Details |
| 26247464 |
2015 |
rs2042004 |
USA |
LOC339166 |
Details |
| 26247464 |
2015 |
SMAD4 amplification |
USA |
SMAD4 |
Details |
| 26247464 |
2015 |
SMAD4 deletion |
USA |
SMAD4 |
Details |
| 30515785 |
2019 |
NOTCH1 mutation |
USA |
NOTCH1 |
Details |
| 30787262 |
2019 |
TP53 mutant R248Q |
USA |
TP53 |
Details |
| 31308744 |
2019 |
Silencing of LINC01116 |
USA |
LINC01116 |
Details |
| 31516747 |
2019 |
PIK3CA mutation |
USA |
PIK3CA |
Details |
| 31819048 |
2019 |
LCN2 promoter methylation |
USA |
LCN2 |
Details |
| 32082486 |
2020 |
SMPD3 methylation |
Canada |
SMPD3 |
Details |
| 32082486 |
2020 |
SMPD3 silencing |
Canada |
SMPD3 |
Details |
| 32115621 |
2020 |
Adgrb3(BAI3) SNV |
USA |
ADGRB3 |
Details |
| 32115621 |
2020 |
BRINP2 SNV |
USA |
BRINP2 |
Details |
| 32115621 |
2020 |
CAP2 SNV |
USA |
CAP2 |
Details |
| 32115621 |
2020 |
CELSR1 SNV |
USA |
CELSR1 |
Details |
| 32115621 |
2020 |
CELSR3 amplification |
USA |
CELSR3 |
Details |
| 32115621 |
2020 |
CELSR3 SNV |
USA |
CELSR3 |
Details |
| 32115621 |
2020 |
COL1A1 amplification |
USA |
COL1A1 |
Details |
| 32115621 |
2020 |
COL6A4 (COL6A4P1) amplification |
USA |
COL6A4P1 |
Details |
| 32115621 |
2020 |
COL6A4 (COL6A4P1) SNV |
USA |
COL6A4P1 |
Details |
| 32115621 |
2020 |
DDR1 amplification |
USA |
DDR1 |
Details |
| 32115621 |
2020 |
DDR1 SNV |
USA |
DDR1 |
Details |
| 32115621 |
2020 |
Egfr amplification |
USA |
EGFR |
Details |
| 32115621 |
2020 |
FAT2 SNV |
USA |
FAT2 |
Details |
| 32115621 |
2020 |
FAT4 SNV |
USA |
FAT4 |
Details |
| 32115621 |
2020 |
ITGA3 amplification |
USA |
ITGA3 |
Details |
| 32115621 |
2020 |
ITGA4 amplification |
USA |
ITGB4 |
Details |
| 32115621 |
2020 |
LAMA1 SNV |
USA |
LAMA1 |
Details |
| 32115621 |
2020 |
NCOR1 amplification |
USA |
NCOR1 |
Details |
| 32115621 |
2020 |
NOTCH1 SNV |
USA |
NOTCH1 |
Details |
| 32115621 |
2020 |
PCDH11X amplification |
USA |
PCDH11X |
Details |
| 32115621 |
2020 |
PCDH11X SNV |
USA |
PCDH11X |
Details |
| 32115621 |
2020 |
PIK3C2A amplification |
USA |
PIK3C2A |
Details |
| 32115621 |
2020 |
PIK3CA amplification |
USA |
PIK3CA |
Details |
| 32115621 |
2020 |
PIK3CB amplification |
USA |
PIK3CB |
Details |
| 32115621 |
2020 |
PIK3IP1 amplification |
USA |
PIK3IP1 |
Details |
| 32115621 |
2020 |
PIK3R1 amplification |
USA |
PIK3R1 |
Details |
| 32115621 |
2020 |
PIK3R3 amplification |
USA |
PIK3R3 |
Details |
| 32115621 |
2020 |
PIK3R4 amplification |
USA |
PIK3R4 |
Details |
| 32115621 |
2020 |
PIK3R5 amplification |
USA |
PIK3R5 |
Details |
| 32115621 |
2020 |
PIK3R6 amplification |
USA |
PIK3R6 |
Details |
| 32115621 |
2020 |
PLEC amplification |
USA |
PLEC |
Details |
| 32115621 |
2020 |
PLEC SNV |
USA |
PLEC |
Details |
| 32251686 |
2020 |
Deletion of 181,257,187-181,247,386 at 5q35.3 |
USA |
NA |
Details |
| 32630820 |
2020 |
DSPP silencing |
USA |
DSPP |
Details |
| 32630820 |
2020 |
MMP20 silencing |
USA |
MMP20 |
Details |
| 33710605 |
2021 |
PAK4 promoter methylation |
USA |
PAK4 |
Details |
| 33710605 |
2021 |
RELA promoter methylation |
USA |
RELA |
Details |
| 34090518 |
2021 |
ABCA2 methylation |
USA |
ABCA2 |
Details |
| 34090518 |
2021 |
CACNA1H methylation |
USA |
CACNA1H |
Details |
| 34090518 |
2021 |
CCNJL methylation |
USA |
CCNJL |
Details |
| 34090518 |
2021 |
GPR133 methylation |
USA |
ADGRD1 |
Details |
| 34090518 |
2021 |
HGFAC methylation |
USA |
HGFAC |
Details |
| 34090518 |
2021 |
HORMAD2 methylation |
USA |
HORMAD2 |
Details |
| 34090518 |
2021 |
MCPH1 methylation |
USA |
MCPH1 |
Details |
| 34090518 |
2021 |
MYLK methylation |
USA |
MYLK |
Details |
| 34090518 |
2021 |
RNF227 methylation |
USA |
RNF216 |
Details |
| 34090518 |
2021 |
SOX8 methylation |
USA |
SOX8 |
Details |
| 34090518 |
2021 |
TRPA1 methylation |
USA |
TRPA1 |
Details |
| 34090518 |
2021 |
WDR86 methylation |
USA |
WDR86 |
Details |